3. Segment Information (Tables)

12 Months Ended

Jun. 30, 2022

3. Segment Information (Tables)

Segment information

Year Ended June 30, 2022	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate			Consolidated
Revenues	$	9,981,100	$	1,419,400		$	-		$	11,400,500
Foreign Sales		3,702,400		1,101,400			-			4,803,800
Income (Loss) From Operations		1,475,800		(7,089,400	)		(1,650,400	)		(7,264,000	)
Assets		9,538,600		10,402,800			9,090,200			29,031,600
Long-Lived Asset Expenditures		92,500		732,100			-			824,600
Depreciation and Amortization		96,300		591,900			-			688,200

Year Ended June 30, 2021	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate			Consolidated
Revenues	$	9,043,600	$	731,600		$	-		$	9,775,200
Foreign Sales		3,483,700		684,600			-			4,168,300
Income (Loss) From Operations		1,461,300		(4,828,600	)		(1,341,400	)		(4,708,700	)
Assets		14,783,000		8,735,100			5,488,300			29,006,400
Long-Lived Asset Expenditures		60,500		196,900			-			257,400
Depreciation and Amortization		103,100		148,400			-			251,500